Titlebook: Stroke Revisited: Diabetes in Stroke; Seung-Hoon Lee,Dong-Wan Kang Book 2021 The Editor(s) (if applicable) and The Author(s), under exclus

走路左晃右晃

連系

Future Therapies for Diabetesr diabetes that aims to replace lost pancreatic beta cells. However, donor shortage is a problem. As an alternative to pancreatic islets derived from human donors, one option would be artificial functional pancreatic islet cells (bioartificial pancreatic islets). One such system, created using human

拍翅

Metformin and Sulfonylureaary to review the clinical efficacy and safety of these old drugs to prevent stroke and reconsider their position. This chapter outlines the mechanisms of these two drugs, focusing on CV disease and the clinical evidence for their CV safety, particularly in stroke.

隼鷹

Dipeptidyl Peptidase-4 Inhibitorshypoglycemia. DPP-4 inhibitors do not increase or decrease the risk of cardiovascular events including stroke. They are efficacious in glucose-lowering action and provide good tolerability and safety profiles.

Coordinate

facilitate

Macro- and Microvascular Complications of Diabetescelerated under hyperglycemic conditions and leads to cardiovascular diseases, which is a top cause of death in patients with diabetes. Microvascular complications arise from injuries of small vessels including capillaries and small arterioles. Classic diabetic microvascular complications include di

密碼

amplitude

Clinical Impact of Diabetes Mellitus in Cardiovascular Diseasesc patients than in nondiabetic patients. Peripheral artery disease is one of the most advanced atherosclerotic vascular complications of diabetes. The presence of peripheral artery disease is closely related to the risk of myocardial infarction, cerebral infarction, and mortality. Poor glycemic cont

發(fā)起

curriculum